COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations with Infecting Genotype, Vaccine History, and Return to Health

EPICC COVID-19 Cohort Study Group, Stephanie A. Richard*, Nusrat J. Epsi, David A. Lindholm, Allison M.W. Malloy, Ryan C. Maves, Catherine M. Berjohn, Tahaniyat Lalani, Alfred G. Smith, Rupal M. Mody, Anuradha Ganesan, Nikhil Huprikar, Rhonda E. Colombo, Christopher J. Colombo, Cristian Madar, Milissa U. Jones, Derek T. Larson, Evan C. Ewers, Samantha Bazan, Anthony C. FriesCarlos J. Maldonado, Mark P. Simons, Julia S. Rozman, Liana Andronescu, Katrin Mende, David R. Tribble, Brian K. Agan, Timothy H. Burgess, Simon D. Pollett, John H. Powers, J. Cowden, M. Darling, S. Deleon, A. Markelz, K. Mende, S. Merritt, T. Merritt, N. Turner, T. Wellington, S. Bazan, C. Mount, M. Stein, C. Berjohn, T. Burgess, C. Byrne, K. Chung, C. Olsen, S. Richard, J. Rusiecki, A. Scher, C. Schofield

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations with Infecting Genotype, Vaccine History, and Return to Health'. Together they form a unique fingerprint.

Medicine & Life Sciences